These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10792469)

  • 1. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism.
    Evatt BL; Robillard L
    Haemophilia; 2000 May; 6(3):131-4. PubMed ID: 10792469
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanding hemophilia care in developing countries.
    O'Mahony B; Black C
    Semin Thromb Hemost; 2005 Nov; 31(5):561-8. PubMed ID: 16276465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WFH: back to the future.
    O'Mahony B
    Haemophilia; 2004 Oct; 10 Suppl 4():1-8. PubMed ID: 15479364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic aspects of haemophilia care in the United States.
    Haemophilia; 1999 Jul; 5(4):282-5. PubMed ID: 10950621
    [No Abstract]   [Full Text] [Related]  

  • 5. Demographics of hemophilia in developing countries.
    Evatt BL
    Semin Thromb Hemost; 2005 Nov; 31(5):489-94. PubMed ID: 16276455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing a harmonized haemophilia registry for countries with developing health care systems.
    Alzoebie A; Belhani M; Eshghi P; Kupesiz AO; Ozelo M; Pompa MT; Potgieter J; Smith M
    Haemophilia; 2013 Sep; 19(5):668-73. PubMed ID: 23590670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia care in developing countries. A report of a joint WHO/World Federation of Hemophilia meeting. Geneva, Switzerland, 16-17 June 1997.
    Haemophilia; 1998; 4 Suppl 2():v, 1-66. PubMed ID: 9988580
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing models of haemophilia care.
    Street A
    Haemophilia; 2012 Jul; 18 Suppl 4():89-93. PubMed ID: 22726089
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences between developed and developing countries in paediatric care in haemophilia.
    De Kleijn P; Odent T; Berntorp E; Hilliard P; Pasta G; Srivastava A; Iliescu A; Mohanty S
    Haemophilia; 2012 Jul; 18 Suppl 4():94-100. PubMed ID: 22726090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilia care in India: innovations and integrations by various chapters of Haemophilia Federation of India (HFI).
    Ghosh K; Shetty S; Sahu D
    Haemophilia; 2010 Jan; 16(1):61-5. PubMed ID: 19780846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BioMarin Defends Up-to-$3M List Price of Hemophilia A Gene Therapy.
    Philippidis A
    Hum Gene Ther; 2020 Aug; 31(15-16):791-793. PubMed ID: 32845777
    [No Abstract]   [Full Text] [Related]  

  • 12. Mission of World Federation of Haemophilia, Biotechnology and treatment for all? The paradox.
    Liras A
    Haemophilia; 2008 Sep; 14(5):920-2. PubMed ID: 18624699
    [No Abstract]   [Full Text] [Related]  

  • 13. Common themes and challenges in hemophilia care: a multinational perspective.
    Stoffman J; Andersson NG; Branchford B; Batt K; D'Oiron R; Escuriola Ettingshausen C; Hart DP; Jiménez Yuste V; Kavakli K; Mancuso ME; Nogami K; Ramírez C; Wu R
    Hematology; 2019 Dec; 24(1):39-48. PubMed ID: 30073913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of haemophilia and its complications in developing countries.
    Ghosh K
    Clin Lab Haematol; 2004 Aug; 26(4):243-51. PubMed ID: 15279660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health aid and governance in developing countries.
    Fielding D
    Health Econ; 2011 Jul; 20(7):757-69. PubMed ID: 20575152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
    Berntorp E; Astermark J; Björkman S; Blanchette VS; Fischer K; Giangrande PL; Gringeri A; Ljung RC; Manco-Johnson MJ; Morfini M; Kilcoyne RF; Petrini P; Rodriguez-Merchan EC; Schramm W; Shapiro A; van den Berg HM; Hart C
    Haemophilia; 2003 May; 9 Suppl 1():1-4. PubMed ID: 12709030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of haemophilia care in the developing world.
    Srivastava A
    Haemophilia; 1998; 4 Suppl 2():33-40. PubMed ID: 9873894
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemophilia treatment in developing countries: products and protocols.
    Srivastava A; You SK; Ayob Y; Chuansumrit A; de Bosch N; Perez Bianco R; Ala F
    Semin Thromb Hemost; 2005 Nov; 31(5):495-500. PubMed ID: 16276456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophilia replacement therapy in developing countries: complementary approaches to the question of indigenous product manufacture versus importation.
    Gellert GA
    Thromb Haemost; 1996 Feb; 75(2):373-4. PubMed ID: 8815594
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of hemophilia with minimal factor replacement in developing countries: role of ancillary therapy.
    Chandy M
    Semin Thromb Hemost; 2005 Nov; 31(5):501-6. PubMed ID: 16276457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.